Effect of Immunoglobulin Therapy on the Rate of Infections in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation or Treated with Immunomodulatory Agents
2010

Impact of Immunoglobulin Therapy on Infections in Multiple Myeloma Patients

Sample size: 47 publication Evidence: moderate

Author Information

Author(s): Khalafallah Alhossain, Maiwald Matthias, Cox Amanda, Burns Denise, Bates Gerald, Hannan Terry, Seaton David, Fernandopulle Bernadene, Meagher Damien, Brain Terry

Primary Institution: Launceston General Hospital

Hypothesis

Does intravenous immunoglobulin therapy reduce the rate of infections in multiple myeloma patients undergoing treatment?

Conclusion

Intravenous immunoglobulin therapy significantly reduces the rate of infections in multiple myeloma patients treated with immunomodulatory agents or undergoing autologous stem cell transplantation.

Supporting Evidence

  • Patients receiving IVIG therapy showed a significant decline in infection rates.
  • The median residual IgG level improved significantly after IVIG therapy.
  • No recorded admissions for severe infections were noted after IVIG therapy.

Takeaway

This study found that giving special antibodies to multiple myeloma patients helps them get fewer infections while they are being treated.

Methodology

Retrospective analysis of 47 multiple myeloma patients receiving immunomodulatory therapy and IVIG treatment.

Potential Biases

Potential selection bias due to the retrospective nature of the study.

Limitations

The study is retrospective and may not account for all variables affecting infection rates.

Participant Demographics

Median age of participants was 64 years, with a female-to-male ratio of 18:29.

Statistical Information

P-Value

p=0.03

Confidence Interval

95% CI 0.09 to 0.19

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.4084/MJHID.2010.005

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication